Oncology Position

[anonymous]

Yes, but some more than others. This one could get ugly fast. Revenue likely less than $8M in 2018, could easily be only half of that.

You don’t know jack. Easily $150M in the first 6 months post approval. Take it to the bank.

 

[anonymous]

$150 million? This will be at least $300 million....no...$500 million in first 6 months, docs cant wait to dump opdivo and keytruda in place of metoovamab....brand name Caboose! You can take that to the bank....but not your bonus check #regret

 

[anonymous]

You don’t know jack. Easily $150M in the first 6 months post approval. Take it to the bank.

Dream on.

 

[anonymous]

You don’t know jack. Easily $150M in the first 6 months post approval. Take it to the bank.

Agreed, but only if it cost $75k per dose.

 

[anonymous]

cemip is DOA.

 

[anonymous]

strategy: see praluent

 

[anonymous]

Get a life you sad, pathetic haters.

 

[anonymous]

Get a life you sad, pathetic haters.

Just telling the truth.

 

[anonymous]

It's almost the end of Q1. When are they going to finish submitting the BLA? Looking at Q3 approval at the earliest now. The longer it takes to get approval, the further behind we are. Merck just needs a study that will get them a NCCN recommendation and this is over before it starts.

 

[anonymous]

New flash genius: a largely Medicare population and a miscellaneous J code, it's already over.

 

[anonymous]

It's almost the end of Q1. When are they going to finish submitting the BLA? Looking at Q3 approval at the earliest now. The longer it takes to get approval, the further behind we are. Merck just needs a study that will get them a NCCN recommendation and this is over before it starts.

I hate to break it to you, Merck has a phIII trial now that is going to take the CSCC indication. They have the business and a j-code. I turned this position down because there is no career in immunology, it's a commodity.

 

[anonymous]

we have regeneron science....we will conquer all...billion dollar drug within a year

 

[anonymous]

Still have several rep jobs posted in TX, NorCal, and OR/SE. Probably very low incidence of CSCC in NW. Do hispanics get CSCC?

 

[anonymous]

we have regeneron science....we will conquer all...billion dollar drug within a year

It’s better to keep your mouth shut and appear stupid than open it and remove all doubt.

 

[anonymous]

I hate to break it to you, Merck has a phIII trial now that is going to take the CSCC indication. They have the business and a j-code. I turned this position down because there is no career in immunology, it's a commodity.

Agreed, and there is no such thing as a 6th-mover advantage.

 

[anonymous]

Still have several rep jobs posted in TX, NorCal, and OR/SE. Probably very low incidence of CSCC in NW. Do hispanics get CSCC?

Mosty old white guys in the sunbelt.

 

[anonymous]

I hate to break it to you, Merck has a phIII trial now that is going to take the CSCC indication. They have the business and a j-code. I turned this position down because there is no career in immunology, it's a commodity.

There is no 6th-mover advantage.

 

[anonymous]

SoCal rep job is still posted. Bueller?

 

[anonymous]

SoCal rep job is still posted. Bueller?

Lots of smart people in SoCal.

 

[anonymous]

2 more days to achieve the completed BLA submission in Q1.